With only three companies in the world making insulin, steep price jumps over recent decades for the vital drug that combats diabetes amount to "price gouging, plain and simple," according to one US senator. Read Full Article at RT.com
With only three companies in the world making insulin, steep price jumps over recent decades for the vital drug that combats diabetes amount to "price gouging, plain and simple," according to one US senator. Read Full Article at RT.com